Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes

by Gordon R.R., Wu M., Huang C.-Y., Harris W.P., Sim H.G., Lucas J.M., Coleman I., Higano C.S., Gulati R., True L.D., Vessella R., Lange P.H., Garzotto M., Beer T.M., Nelson P.S.
Published 2019